Gene Patent Panic

Your biotech startup's breakthrough cancer therapy relies on CRISPR-modified genes. Morgan Chen, representing PharmaTech Giants, claims your research infringes on their patents. You have 15 minutes to negotiate before they file an injunction that would halt all trials and bankrupt your company.

Challenges

Survivors

Popularity

Difficulty

B1-B2

Start Practicing Now

Scenario Overview

Your Role

Dr. Sarah Martinez, CEO of NovaCure Therapeutics

Conversation Partner

Morgan Chen, Head of IP Enforcement, PharmaTech Giants

Setting

Glass-walled conference room on the 47th floor, city lights twinkling ominously through rain-streaked windows

Location

Downtown Financial District, Legal Offices of Sterling & Myers

Learning Objectives

✓

Negotiate continuation of clinical trials without complete patent surrender

✓

Uncover weaknesses in PharmaTech's patent claims

✓

Secure a deal that keeps your company operational

About This Scenario

How It Starts

“Dr. Martinez, I have our legal team on standby to file federal injunctions across all jurisdictions where you're conducting trials. That's what, six states? Your call - we can discuss a reasonable solution, or I can make that call right now.”

This is how Morgan Chen, Head of IP Enforcement, PharmaTech Giants's greeting will start.

Practice Details

Scenario ID

#1633

What You'll Get

🎯Real-world conversation practice
🤖AI-powered speaking partner
📊Instant feedback on your performance
🎓Learn from your mistakes

Other Scenarios to Explore

Similar scenarios coming soon

Ready to Practice?

Start your speaking journey with BoldSpeak today. Sign up for free and get unlimited access to scenarios.

Get Started Free